Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Department of Medical Imaging
Department Chair: Prof. Corinne Balleyguier
Medical imaging plays a vital role at every stage of cancer care: diagnosis, assessment of the extent of the disease, preparation for treatment, and monitoring of treatment effectiveness.
At Gustave Roussy, the diagnostic imaging, nuclear medicine, and endocrine oncology teams rely on state-of-the-art equipment to provide patients with accurate examinations tailored to their specific situations, as well as next-generation treatments such as vectorized internal radiation therapy.
Within the department, the nuclear medicine and endocrine oncology teams also offer targeted cancer treatments—some of which are next-generation—such as vectorized internal radiation therapy for thyroid cancer, endocrine tumors, and prostate tumors (iodine-131, Lu-DOTATATE, Lu-PSMA), both as part of routine clinical practice and within the framework of Phase I through III clinical trials.
Take it from an expert
Prof. Corinne Balleyguier
Head of the Department of Medical Imaging
Imaging has become an essential tool in precision medicine. Our goal is to provide every patient with the most reliable information to guide treatment decisions and evaluate the effectiveness of treatments throughout their care journey.
Technical Facilities
-
3
scanners, including 2 photonic scanners
-
2
MRI (+ 1 currently being installed)
-
2
PET Scan
-
2
gamma cameras
-
3
mammography units with 3 dedicated ultrasound machines for breast ultrasound
-
1
dedicated radiology room
-
4
ultrasound rooms
Our Areas of Expertise
Diagnostic Imaging Department
The department performs imaging studies to detect and characterize tumors, assess their extent, and monitor the effectiveness of treatments.
The main imaging modalities used are:
- Ultrasound
- CT scan
- MRI
- Mammography
- Breast tomosynthesis
- Angiomammography
- Interventional Breast and Soft Tissue Imaging
Nuclear Medicine Department
The department uses radioactive molecules for diagnostic or therapeutic purposes (radiopharmaceuticals) to obtain functional information about tumors.
The exams performed include, in particular:
- Scintigraphy
- PET scan with multiple tracers
- Therapies using radioactive isotopes or targeted internal radiation therapy (TIRT)
Endocrine Oncology
The department provides specialized care for:
- Thyroid cancers
- Adrenal gland tumors
- Neuroendocrine tumors
- Prostate cancer
- Breast cancer, gastrointestinal cancers, ENT cancers, and others as part of clinical trials (Phases I–III).
What is nuclear medicine?
Nuclear medicine is a medical specialty that uses small amounts of radioactive substances to visualize certain bodily functions or treat certain tumors. It often supplements the information obtained from CT or MRI scans and helps characterize the tumor from a functional perspective.
Exams Offered
A test that uses X-rays to produce detailed images of the body.
A technique that uses a magnetic field to accurately visualize organs and tissues.
An ultrasound-based examination, frequently used to evaluate certain masses or guide biopsies.
The gold standard imaging test for evaluating breast abnormalities.
A nuclear medicine scan used to observe tissue metabolic activity, identify specific tumor targets, assess the extent of certain cancers, and monitor response to treatment
A functional test used to evaluate the functioning of certain organs or tissues.
Research and Innovation
The teams are involved in numerous research projects aimed at improving the accuracy of diagnoses and the evaluation of treatments.
Diagnostic Imaging
- Evaluation of Breast Tomosynthesis
- Development of angiomammography
- Artificial Intelligence in Breast Imaging and Oncology
- Personalized breast cancer screening
- Development of Spectral Imaging and Photon-Counting CT in Oncology
- Evaluation of whole-body MRI and functional MRI protocols
- New criteria for evaluating treatment response in clinical research
- Lung cancer screening using low-dose CT
Nuclear Medicine
- Introduction of new isotopes and new radiopharmaceuticals
- Participation in innovative therapeutic trials
- Personalized dosimetry
Endocrine Oncology
- Participation in innovative therapeutic trials
- Contribution to large multicenter cohorts supported by INCa
Team
Management Team
- Prof. Corinne Balleyguier, Department Chair and Head of the Diagnostic Imaging Division.
- Dr. Désirée Deandreis, Associate Head of the Department of Medical Imaging and Head of the Nuclear Medicine Unit + link
- Dr. Livia Lamartina, Head of the Endocrine Oncology Unit effective October 1, 2026
Coordination
- Simon Corbin, Medical-Technical Coordinator
- Marie-Stéphanie Bour, Deputy Management Executive
- Véronica Forte, Medical Secretariat Manager
Contacts
Department of Medical Imaging
Administrative Office Tel.: +33 (0)1 42 11 43 99
Diagnostic Imaging Department
- Main Office: +33 (0)1 42 11 48 73
- Healthcare Manager: +33 (0)1 42 11 45 09
Department of Nuclear Medicine and Endocrinology
- New Patients: +33 (0)1 42 11 57 94
- Main Office: +33 (0)1 42 11 60 95
- Head Nurse: +33 (0)1 42 11 42 68
Join us
Are you interested in a career in medical imaging?
Imaging teams are hiring regularly!
For any questions regarding opportunities within the Department of Medical Imaging: